Adverse events | Safety population (n = 80) |
---|---|
Patient with ≥1 grade 3–4 adverse event | 48 (60.0) |
Neutropenia | 16 (20.0) |
Decreased neutrophil counta | 11 (13.8) |
Anemia | 9 (11.3) |
Pneumonia | 7 (8.8) |
Decreased white blood cell count | 6 (7.5) |
Leukopenia | 5 (6.3) |
Thrombocytopenia | 5 (6.3) |
Upper respiratory tract infection | 5 (6.3) |
Fatigue | 4 (5.0) |
Decreased platelet count | 4 (5.0) |
Hypocalcemia | 3 (3.8) |
Hypokalemia | 3 (3.8) |